ArticleEMBO molecular medicine2018

A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.

Mfon E Umoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.